Study of methods for state regulation of prices and costs of the health care system for medicines in the United Kingdom
Objective: analysis of state regulation of prices and costs for the purchase of medicines (drugs) in the United Kingdom (UK), and proposal development to improve the processes of state regulation of manufacturers’ marginal registered prices of medicines included in the list of vital and essential dr...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2022-04-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/656 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849249564419162112 |
|---|---|
| author | A. A. Leshkevich D. S. Yurochkin Z. M. Golant I. A. Narkevich |
| author_facet | A. A. Leshkevich D. S. Yurochkin Z. M. Golant I. A. Narkevich |
| author_sort | A. A. Leshkevich |
| collection | DOAJ |
| description | Objective: analysis of state regulation of prices and costs for the purchase of medicines (drugs) in the United Kingdom (UK), and proposal development to improve the processes of state regulation of manufacturers’ marginal registered prices of medicines included in the list of vital and essential drugs approved in the Russian Federation.Material and methods. Analysis of the structure of state regulation of prices and costs for the procurement of drugs was carried out based on information contained in the regulatory legal documents of the UK Government, health services and technical regulation, and data provided in systematic reviews and articles.Results. A key feature of regulation in the UK is maximizing the efficiency of health care costs based on the principles of digitization, long-term planning and health technology assessment in pricing. Government regulation of costs is focused on the patent-protected drug segment. Providers of such medicines fall under the Voluntary or Statutory Scheme and are required to make payments in the form of a fixed percentage of sales to the Department of Health and Social Care. Certain drug segments are exempt from payments to stimulate innovative development of the pharmaceutical industry and accelerate market access for new therapies. As practice shows, the Voluntary Scheme is more profitable for most companies. Regulation in the segment of reproduced drugs is carried out by free-market mechanisms and the antimonopoly service.Conclusion. The analysis revealed the mechanisms and key features of the methods of state regulation of prices and costs of the health care system for the procurement of drugs, identified best practices that are promising for adaptation to improve the state regulation of prices in the Russian Federation. |
| format | Article |
| id | doaj-art-ce59c12148f74fa8b24c88b53e6fd95a |
| institution | Kabale University |
| issn | 2070-4909 2070-4933 |
| language | Russian |
| publishDate | 2022-04-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Фармакоэкономика |
| spelling | doaj-art-ce59c12148f74fa8b24c88b53e6fd95a2025-08-20T03:57:31ZrusIRBIS LLCФармакоэкономика2070-49092070-49332022-04-01151233910.17749/2070-4909/farmakoekonomika.2022.102378Study of methods for state regulation of prices and costs of the health care system for medicines in the United KingdomA. A. Leshkevich0D. S. Yurochkin1Z. M. Golant2I. A. Narkevich3Saint Petersburg State Chemical Pharmaceutical UniversitySaint Petersburg State Chemical Pharmaceutical UniversitySaint Petersburg State Chemical Pharmaceutical UniversitySaint Petersburg State Chemical Pharmaceutical UniversityObjective: analysis of state regulation of prices and costs for the purchase of medicines (drugs) in the United Kingdom (UK), and proposal development to improve the processes of state regulation of manufacturers’ marginal registered prices of medicines included in the list of vital and essential drugs approved in the Russian Federation.Material and methods. Analysis of the structure of state regulation of prices and costs for the procurement of drugs was carried out based on information contained in the regulatory legal documents of the UK Government, health services and technical regulation, and data provided in systematic reviews and articles.Results. A key feature of regulation in the UK is maximizing the efficiency of health care costs based on the principles of digitization, long-term planning and health technology assessment in pricing. Government regulation of costs is focused on the patent-protected drug segment. Providers of such medicines fall under the Voluntary or Statutory Scheme and are required to make payments in the form of a fixed percentage of sales to the Department of Health and Social Care. Certain drug segments are exempt from payments to stimulate innovative development of the pharmaceutical industry and accelerate market access for new therapies. As practice shows, the Voluntary Scheme is more profitable for most companies. Regulation in the segment of reproduced drugs is carried out by free-market mechanisms and the antimonopoly service.Conclusion. The analysis revealed the mechanisms and key features of the methods of state regulation of prices and costs of the health care system for the procurement of drugs, identified best practices that are promising for adaptation to improve the state regulation of prices in the Russian Federation.https://www.pharmacoeconomics.ru/jour/article/view/656pricing methodologystate regulation of drug prices in the united kingdombranded medicinesgeneric medicineshealth care digitization |
| spellingShingle | A. A. Leshkevich D. S. Yurochkin Z. M. Golant I. A. Narkevich Study of methods for state regulation of prices and costs of the health care system for medicines in the United Kingdom Фармакоэкономика pricing methodology state regulation of drug prices in the united kingdom branded medicines generic medicines health care digitization |
| title | Study of methods for state regulation of prices and costs of the health care system for medicines in the United Kingdom |
| title_full | Study of methods for state regulation of prices and costs of the health care system for medicines in the United Kingdom |
| title_fullStr | Study of methods for state regulation of prices and costs of the health care system for medicines in the United Kingdom |
| title_full_unstemmed | Study of methods for state regulation of prices and costs of the health care system for medicines in the United Kingdom |
| title_short | Study of methods for state regulation of prices and costs of the health care system for medicines in the United Kingdom |
| title_sort | study of methods for state regulation of prices and costs of the health care system for medicines in the united kingdom |
| topic | pricing methodology state regulation of drug prices in the united kingdom branded medicines generic medicines health care digitization |
| url | https://www.pharmacoeconomics.ru/jour/article/view/656 |
| work_keys_str_mv | AT aaleshkevich studyofmethodsforstateregulationofpricesandcostsofthehealthcaresystemformedicinesintheunitedkingdom AT dsyurochkin studyofmethodsforstateregulationofpricesandcostsofthehealthcaresystemformedicinesintheunitedkingdom AT zmgolant studyofmethodsforstateregulationofpricesandcostsofthehealthcaresystemformedicinesintheunitedkingdom AT ianarkevich studyofmethodsforstateregulationofpricesandcostsofthehealthcaresystemformedicinesintheunitedkingdom |